tiprankstipranks
Advertisement
Advertisement

Quipt Home Medical Shareholders Approve Going-Private Acquisition Plan

Story Highlights
  • Quipt shareholders overwhelmingly approved a March 3, 2026, cash acquisition at US$3.65 per share.
  • The vote advances a going-private deal pending court and regulatory approvals, impacting ownership and strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Quipt Home Medical Shareholders Approve Going-Private Acquisition Plan

Claim 30% Off TipRanks

Quipt Home Medical ( (TSE:QIPT) ) has issued an announcement.

On March 3, 2026, Quipt Home Medical shareholders approved a special resolution for a plan of arrangement under British Columbia corporate law, clearing the way for affiliates of private equity firms Kingswood Capital Management and Forager Capital Management to acquire all outstanding Quipt shares for US$3.65 in cash per share. The deal won overwhelming support, with approximately 66.93% of outstanding shares represented at the Sarasota, Florida meeting and about 98.9% of votes cast in favor overall, and 98.7% in favor on a minority basis under MI 61-101, positioning the company for a going-private transaction subject to final court and regulatory approvals.

Quipt plans to seek a final order from the Supreme Court of British Columbia on March 5, 2026, after which the transaction is expected to close once remaining regulatory and stock exchange conditions are satisfied. For shareholders, the vote marks a decisive step toward crystallizing value at a fixed cash price, while for the company and its new sponsors, the arrangement is set to shift Quipt off the public markets and into private ownership, potentially altering its capital structure and strategic flexibility within the competitive home medical and respiratory care sector.

The most recent analyst rating on (TSE:QIPT) stock is a Hold with a C$5.00 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Neutral.

The score is driven by mixed fundamentals: strong revenue growth and positive free cash flow support the profile, but ongoing losses, negative ROE, and moderate-to-elevated leverage meaningfully cap the rating. Technicals are supportive with an uptrend versus key moving averages, while valuation is penalized because earnings are negative and there is no dividend yield data.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. is a U.S.-based home medical equipment provider focused on end-to-end respiratory care and broader in-home monitoring and chronic disease management services. The company targets patients with heart and pulmonary disease, sleep disorders, reduced mobility and other chronic conditions in the U.S. healthcare market, aiming to grow by offering multiple integrated services per patient to increase revenue and simplify care.

Average Trading Volume: 52,393

Technical Sentiment Signal: Buy

Current Market Cap: C$220.5M

Learn more about QIPT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1